Drug Type Small molecule drug |
Synonyms Easytrip, 이지트립시럽 |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (09 Feb 2026), |
Regulation- |
Molecular FormulaC20H23ClN2O4 |
InChIKeyDBAKFASWICGISY-BTJKTKAUSA-N |
CAS Registry113-92-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Motion Sickness | South Korea | 09 Feb 2026 |





